| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
1 Academic Unit of Cancer Studies, University of Nottingham, Nottingham, and 2 Department of Cancer Biomarkers, University of Leicester, Leicester, United Kingdom
Mechanisms by which premalignant Barrett’s metaplasia (BM) progresses to esophageal adenocarcinoma are currently being sought. This study investigated the role played by the polypeptide hormone gastrin, specifically its antiapoptotic effects through activation of protein kinase B/Akt (PKB/Akt). In esophageal cell lines with low basal levels of activated PKB/Akt, phosphorylation could be induced by exogenous amidated gastrin. High basal levels of activated PKB/Akt were linked to endogenous gastrin expression and were reduced by treatment with a cholecystokinin-type 2 receptor (CCK-2R) antagonist. Expression of a constitutively active splice variant of the CCK-2R additionally increased basal activation of PKB/Akt. It is proposed that gastrin acting in an autocrine and endocrine manner via a CCK-2R isoform may activate PKB/Akt and that with expression of gastrin and CCK-2R isoforms increasing in BM samples, gastrin may aid progression of BM through amplification of antiapoptotic pathways. Evidence for this proposal was provided through the observed specific up-regulation of PKB/Akt in BM samples.
This article has been cited by other articles:
|
|
 |
|
  M. Korner and L. J. Miller Alternative Splicing of Pre-mRNA in Cancer: Focus on G Protein-Coupled Peptide Hormone Receptors Am. J. Pathol., August 1, 2009; 175(2): 461 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. L P Beales and O. O Ogunwobi Glycine-extended gastrin inhibits apoptosis in Barrett's oesophageal and oesophageal adenocarcinoma cells through JAK2/STAT3 activation J. Mol. Endocrinol., April 1, 2009; 42(4): 305 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Pritchard, D. Berry, S. M. C. Przemeck, F. Campbell, S. W. Edwards, and A. Varro Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G798 - G805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Abrams Review: Chemoprevention of esophageal adenocarcinoma Therapeutic Advances in Gastroenterology, July 1, 2008; 1(1): 7 - 18. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Kopelovich, J. R. Fay, C. C. Sigman, and J. A. Crowell The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention Cancer Epidemiol. Biomarkers Prev., July 1, 2007; 16(7): 1330 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R C Fitzgerald Molecular basis of Barrett's oesophagus and oesophageal adenocarcinoma. Gut, December 1, 2006; 55(12): 1810 - 1820. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Paillasse, C. Deraeve, P. de Medina, L. Mhamdi, G. Favre, M. Poirot, and S. Silvente-Poirot Insights into the Cholecystokinin 2 Receptor Binding Site and Processes of Activation Mol. Pharmacol., December 1, 2006; 70(6): 1935 - 1945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Dickson, A. Grabowska, M. El-Zaatari, J. Atherton, and S. A. Watson Helicobacter pylori Can Induce Heparin-Binding Epidermal Growth Factor Expression via Gastrin and Its Receptor. Cancer Res., August 1, 2006; 66(15): 7524 - 7531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dufresne, C. Seva, and D. Fourmy Cholecystokinin and gastrin receptors. Physiol Rev, July 1, 2006; 86(3): 805 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Clarke, J. H. Dickson, J. C. Harris, A. Grabowska, and S. A. Watson Gastrin Enhances the Angiogenic Potential of Endothelial Cells via Modulation of Heparin-Binding Epidermal-Like Growth Factor. Cancer Res., April 1, 2006; 66(7): 3504 - 3512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Chao, K. L. Ives, E. Goluszko, A. A. Kolokoltsov, R. A. Davey, C. M. Townsend Jr., and M. R. Hellmich Src Regulates Constitutive Internalization and Rapid Resensitization of a Cholecystokinin 2 Receptor Splice Variant J. Biol. Chem., September 30, 2005; 280(39): 33368 - 33373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. He, J. Pannequin, J.-P. Tantiongco, A. Shulkes, and G. S. Baldwin Glycine-extended gastrin stimulates cell proliferation and migration through a Rho- and ROCK-dependent pathway, not a Rac/Cdc42-dependent pathway Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G478 - G488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Cui, T. J. Koh, D. Chen, C.-M. Zhao, S. Takaishi, G. J. Dockray, A. Varro, A. B. Rogers, J. G. Fox, and T. C. Wang Overexpression of Glycine-Extended Gastrin Inhibits Parietal Cell Loss and Atrophy in the Mouse Stomach Cancer Res., November 15, 2004; 64(22): 8160 - 8166. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
